NIDCR'S NEW CLINICAL TRIALS PROGRAM
RELEASE DATE: December 9, 2002
NOTICE: NOT-DE-03-002 (Rescinded per Notice NOT-DE-08-002)
National Institute of Dental and Craniofacial Research (NIDCR)
(http://www.nidcr.nih.gov)
PURPOSE OF THIS NOTICE
To inform the research community that the NIDCR will focus its clinical
trials research program on the conduct of definitive, multicenter Phase
III clinical trials. The new clinical trial program to be used by
NIDCR can be viewed at http://www.nidcr.nih.gov at Information for
Investigators under the heading Clinical Trials. NIDCR's use of these
new procedures is effective immediately with the publication of this
notice. All new submissions following the publication of this notice
must conform to this new process. Applications already submitted to
NIH for NIDCR consideration will not be subject to this new process.
Resubmission of applications (amended A1 and A2 applications)
originally submitted under the discontinued NIDCR Clinical Trial
Planning Grant mechanism (PAR-99-157) or the discontinued NIDCR
Clinical Trial Pilot Grant mechanism (PAR-99-158) will not be subject
to this new process if the principal investigator so desires.
The process for submitting a clinical trial proposal, including the
review criteria to be used by NIDCR, is described at
http://www.nidcr.nih.gov.
Each full Phase III clinical trial will consist of the submission of a
minimum of two grant applications: one from the Study Chair and one
from the Data Coordinating Center. The applications for clinical
centers may be submitted as separate grant applications or as
subcontracts to the Study Chair or Data Coordinating Center
applications. Given the complex nature of multicenter Phase III
clinical trials, NIDCR encourages the use of a Data Coordinating Center
as an integral part of the clinical trial organization. As part of the
Study Chairs' application, NIDCR will require the submission of a
detailed Manual of Procedures (MOP). See http://www.nidcr.nih.gov for
a model MOP showing the detail required in a well-written MOP. Another
example of a detail MOP table of content can be found in Meinert, CL,
Clinical Trials Design, Conduct, and Analysis, Oxford University Press,
1986, pp. 417-419.
To assist investigators in preparing the final applications for a
multicenter Phase III clinical trial, in preparing the MOP, and in
finalizing the organizational structure of the clinical trial, the
NIDCR has revised the NIDCR Clinical Trial Planning Grant to support
this activity (see http://www.nidcr.nih.gov).
To provide a mechanism for the collection of preliminary data that is
necessary to support the development of definitive Phase III clinical
trials, NIDCR has developed the NIDCR Clinical Pilot Data Grant (see
http://www.nidcr.nih.gov)
NIDCR will use the U01 cooperative agreement mechanism to support Phase
III clinical trials. Special Terms and Conditions of award will be
associated with these awards since NIDCR staff will have substantive
involvement in the development, conduct, and overall management of
these clinical trials (see http://www.nidcr.nih.gov). Clinical trial
applications will be peer reviewed by an NIDCR special review
committee. Criteria to be used by peer review to evaluate each
application are described at http://www.nidcr.nih.gov.
INQUIRIES
Inquiries are strongly encouraged. Opportunities to clarify any issues
or questions from potential applicants are welcome.
Direct inquiries concerning scope, requirements, and eligibility to:
Jane C. Atkinson, D.D.S.
Program Director, Clinical Trials Program
Center for Clinical Research
National Institute of Dental and Craniofacial Research
Building 45, Room 4AS25L
45 Center Drive, MSC 6401
Bethesda, MD 20892-6401
Telephone (301) 435-7908
E-mail: [email protected]
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
| ||||||
Department of Health and Human Services (HHS) |
||||||
NIH... Turning Discovery Into Health® |